Interferon-gamma produced by encephalitogenic cells induces suppressors of cytokine signaling in primary murine astrocytes

Journal of Neuroimmunology

Volumn 151, Issue 1-2, 2004, Pages 195-200

  Stark, Jennifer L ^a   Lyons, Jeri Anne ^b   Cross, Anne H ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WISCONSIN MILWAUKEE   (United States)

Author keywords

Astrocytes; Experimental autoimmune encephalomyelitis; Immune regulation; Interferon gamma; Suppressors of cytokine signaling

Indexed keywords

CELL PROTEIN; GAMMA INTERFERON; LEUKEMIA INHIBITORY FACTOR; MESSENGER RNA; MYELIN BASIC PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 1; SUPPRESSOR OF CYTOKINE SIGNALING 3; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; ASTROCYTE; CELL CULTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; INFLAMMATION; LYMPHOID CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SUPPRESSOR CELL;

ANIMALS; ASTROCYTES; CARRIER PROTEINS; CELLS, CULTURED; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; GENE EXPRESSION; INTERFERON TYPE II; INTERLEUKIN-6; LEUKEMIA INHIBITORY FACTOR; MICE; MYELIN BASIC PROTEINS; REPRESSOR PROTEINS; RNA, MESSENGER; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; TRANSCRIPTION FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 2442497289     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2004.03.005     Document Type: Article

References (38)

1. Alexander W.S. Suppressors of cytokine signalling (SOCS) in the immune system. Nat. Rev., Immunol. 2:2002;410-416
2. Alexander W.S., Starr R., Fenner J.E., Scott C.L., Handman E., Sprigg N.S., Corbin J.E., Cornish A.L., Darwiche R., Owczarek C.M., Kay T.W.H., Nicola N.A., Hertzog P.J., Metcalf D., Hilton D.J. SOCS-1 is a critical inhibitor of interferon γ signaling and prevents the potentially fatal neonatal actions of this cytokine. Cell. 98:1999;597-608
3. Aloisi F., Rosa S., Testa U., Bonsi P., Russo G., Peschle C., Levi G. Regulation of leukemia inhibitory factor synthesis in cultured human astrocytes. J. Immunol. 152:1994;5022-5031
4. Auernhammer C.J., Chesnokova V., Bousquet C., Melmed S. Pituitary corticotroph SOCS-3: novel intracellular regulation of leukemia-inhibitory factor-mediated proopiomelanocortin gene expression and adrenocorticotropin secretion. Mol. Endocrinol. 12:1998;954-961
5. Bjorbaek C., Elmquist J.K., El-Haschimi K., Kelly J., Ahima R.S., Hileman S., Flier J.S. Activation of SOCS-3 messenger ribonucleic acid in the hypothalamus by ciliary neurotrophic factor. Endocrinology. 140:1999;2035-2043
6. Butzkueven H., Zhang J., Soilu-Hanninen M., Hochrein H., Chionh F., Shipham K.A., Emery B., Turnley A.M., Petratos S., Ernst M., Bartlett P.F., Kilpatrick T.J. LIF receptor signaling limits immune-mediated demyelination by enhancing oligodendrocyte survival. Nat. Med. 8:2002;613-619
7. Cacalano N.A., Sanden D., Johnston J.A. Tyrosine-phosphorylated SOCS-3 inhibits STAT activation but binds to p120 RasGAP and activates Ras. Nat. Cell Biol. 3:2001;460-465
8. Chong M.M.W., Thomas H.E., Kay T.W.H. Suppressor of cytokine signaling-1 regulates the sensitivity of pancreatic β cells to tumor necrosis factor. J. Biol. Chem. 277:2002;27945-27952
9. Crespo A., Filla M.B., Murphy W.J. Low responsiveness to IFN-γ, after pretreatment of mouse macrophages with lipopolysaccharides, develops via diverse regulatory pathways. Eur. J. Immunol. 32:2002;710-719
10. Croker B.A., Krebs D.L., Zhang J., Wormald S., Willson T.A., Stanley E.G., Robb L., Greenhalgh C.J., Forster I., Clausen B.E., Nicola N.A., Metcalf D., Hilton D.J., Roberts A.W., Alexander W.S. SOCS-3 negatively regulates IL-6 signaling in vivo. Nat. Immunol. 4:2003;540-545
11. Cross A.H., Keeling R.M., Goorha S., San M., Rodi C., Wyatt P.S., Manning P.T., Misko T.P. Inducible nitric oxide synthase gene expression and enzyme activity correlate with disease activity in murine experimental autoimmune encephalomyelitis. J. Neuroimmunol. 71:1996;145-153
12. Dalpke A.H., Opper S., Zimmermann S., Heeg K. Suppressors of cytokine signaling (SOCS)-1 and SOCS-3 are induced by CpG-DNA and modulate cytokine responses in APCs. J. Immunol. 166:2001;7082-7089
13. Feinstein D.L., Galea E., Gavrilyuk V., Brosnan C.F., Whitacre C.C., Dumitrescu-Ozimek L., Landreth G.E., Pershadsingh H.A., Weinberg G., Heneka M.T. Peroxisome proliferator-activated receptor-γ agonists prevent experimental autoimmune encephalomyelitis. Ann. Neurol. 51:2002;694-702
14. Glabinski A.R., Balasingam V., Tani M., Kunkel S.L., Strieter R.M., Yong V.W., Ransohoff R.M. Chemokine monocyte chemoattractant protein-1 is expressed by astrocytes after mechanical injury to the brain. J. Immunol. 156:1996;4363-4368
15. Hewett S.J., Corbett J.A., McDaniel M.L., Choi D.W. Interferon-γ and interleukin-1β induce nitric oxide formation from primary mouse astrocytes. Neurosci. Lett. 164:1993;229-232
16. Hewett S.J., Misko T.P., Keeling R.M., Behrens M.M., Choi D.W., Cross A.H. Murine encephalitogenic lymphoid cells induce nitric oxide synthase in primary astrocytes. J. Neuroimmunol. 64:1996;201-208
17. Karpus W.J., Ransohoff R.M. Chemokine regulation of experimental autoimmune encephalomyelitis: temporal and spatial expression patterns govern disease pathogenesis. J. Immunol. 161:1998;2667-2671
18. Lang R., Pauleau A., Parganas E., Takahashi Y., Mages J., Ihle J.N., Rutschman R., Murray P.J. SOCS-3 regulates the plasticity of gp130 signaling. Nat. Immunol. 4:2003;546-550
19. Lieskovska J., Guo D., Derman E. Growth impairment in IL-6-overexpressing transgenic mice is associated with induction of SOCS3 mRNA. Growth Horm. IGF Res. 13:2003;26-35
20. Linker R.A., Maurer M., Gaupp S., Martini R., Holtmann B., Giess R., Rieckmann P., Lassmann H., Toyka K.V., Sendtner M., Gold R. CNTF is a major protective factor in demyelinating CNS disease: a neurotrophic cytokine as modulator in neuroinflammation. Nat. Med. 8:2002;620-624
21. Maier J., Kincaid C., Pagenstecher A., Campbell I.L. Regulation of signal transducer and activator of transcription and suppressor of cytokine-signaling gene expression in the brain of mice with astrocyte-targeted production of interleukin-12 or experimental autoimmune encephalomyelitis. Am. J. Pathol. 160:2002;271-288
22. Morita Y., Naka T., Kawazoe Y., Fujimoto M., Narazaki M., Nakagawa R., Fukuyama H., Nagata S., Kishimoto T. Signals transducers and activators of transcription (STAT)-induced STAT inhibitor-1 (SSI-1)/suppressor of cytokine signaling-1 (SOCS-1) suppresses tumor necrosis factor α-induced cell death in fibroblasts. Proc. Natl. Acad. Sci. 97:2000;5404-5410
23. Naka T., Narazaki M., Hirata M., Matsumoto T., Minamoto S., Aono A., Nishimoto N., Kajita T., Taga T., Yoshizaki K., Akira S., Kishimoto T. Structure and function of a new STAT-induced STAT inhibitor. Nature. 387:1997;924-929
24. Neumann H., Boucraut J., Hahnel C., Misgeld T., Wekerle H. Neuronal control of MHC class II inducibility in rat astrocytes and microglia. Eur. J. Neurosci. 8:1996;2582-2590
25. Norenberg M.D. Astrocyte responses to CNS injury. J. Neuropathol. Exp. Neurol. 53:1994;213-220
26. Olsson T. Cytokines in neuroinflammatory disease: role of myelin autoreactive T cell production of interferon-gamma. J. Neuroimmunol. 40:1992;211-218
27. 2 and rosiglitazone suppress Janus kinase-STAT inflammatory signaling through induction of suppressor of cytokine signaling 1 (SOCS-1) and SOCS-3 in glia. J. Biol. Chem. 278:2003;14747-14752
28. Raine C.S., Scheinberg L.C. On the immunopathology of plaque development and repair in multiple sclerosis. J. Neuroimmunol. 20:1988;189-201
29. Rose K., Goldberg M.P., Choi D.W. Cytotoxicity in murine neocortical cell culture. Tyson C.A., Frazier J.M. In Vitro Biological Methods. 1993;46-60 Academic Press, San Diego, CA
30. Rudge J.S., Morrissey D., Lindsay R.M., Pasnikowski E.M. Regulation of ciliary neurotrophic factor in cultured rat hippocampal astrocytes. Eur. J. Neurosci. 6:1994;218-229
31. Smith M.E., Eng L.F. Glial fibrillary acidic protein in chronic relapsing experimental allergic encephalomyelitis in SJL/J mice. J. Neurosci. Res. 18:1987;203-208
32. Starr R., Willson T.A., Viney E.M., Murray L.J.L., Rayner J.R., Jenkins B.J., Gonda T.J., Alexander W.S., Metcalf D., Nicola N.A., Hilton D.J. A family of cytokine-inducible inhibitors of signaling. Nature. 387:1997;917-921
33. Takeshita S., Takeshita F., Haddad D.E., Janabi N., Klinman D.M. Activation of microglia and astrocytes by CpG oligodeoxynucleotides. NeuroReport. 12:2001;3029-3032
34. Turnley A.M., Starr R., Bartlett P.F. Failure of sensory neurons to express class I MHC is due to differential SOCS-1 expression. J. Neuroimmunol. 123:2002;35-40
35. Van Wagoner N.J., Benveniste E.N. Interleukin-6 expression and regulation in astrocytes. J. Neuroimmunol. 100:1999;124-139
36. Vartanian T., Li Y., Zhao M., Stefansson K. Interferon-gamma-induced oligodendrocyte cell death: implications for the pathogenesis of multiple sclerosis. Mol. Med. 1:1995;732-743
37. Xiao B., Link H. Is there a balance between microglia and astrocytes in regulating Th1/Th2-cell responses and neuropathologies? Immunol. Today. 20:1999;477-479
38. Yasukawa H., Ohishi M., Mori H., Murakami M., Chinen T., Aki D., Hanada T., Takeda K., Akira S., Hoshijima M., Hirano T., Chien K.R., Yoshimura A. IL-6 induces an anti-inflammatory response in the absence of SOCS-3 in macrophages. Nat. Immunol. 4:2003;551-556